Humanitarian NGOs rely on generics


By 2010, such purchases were predominantly generic drugs [56]. For example, by 2008, 95% (by volume) of the global donor-funded ARV market was comprised of generics, primarily from India[57]. The generic proportion of PEPFAR-purchased ARVs grew from 15% to 89% from 2005 to 2008, with estimated savings to PEPFAR totalling $323 million over the four-year period [58].

http://www.biomedcentral.com/1758-2652/14/15#B57

Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
Ellen ‘t Hoen, Jonathan Berger, Alexandra Calmy, and Suerie Moon

 

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s